A Tech Moment: MedPharm Moves Toward Federal Approval

CannabisTech

English - September 03, 2019 00:00 - 11 minutes - 10.9 MB
Tech News News Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: A Tech Moment: Gavin Kogan Discusses Entering the Cannabis Industry

Next Episode: A Tech Moment: Paragon Processing Provides Crop-Saving Services for Hemp Farmers

An interview with Albert Gutierrez, CEO of MedPharm, discussing recent movements by the DEA to move forward with medical cannabis research.

In light of the DEAs recently announcement to start processing new cannabis research applications, Cannabis Tech sat down with Albert Gutierrez, the CEO of MedPharm Research, a leader in cannabis research and formulation development, who has recently received notice that they are one of 32 applicants selected to move forward in the process.

Recently, in the wake of Dr. Sue Sisley’s lawsuit against the DEA, the federal government has been moving forward by approving companies as federally recognized cannabis suppliers. MedPharm is one of the first companies to be selected to move forward with this program.

---

Support this podcast: https://podcasters.spotify.com/pod/show/cannabis-tech/support